Skip to main content

Market Overview

UPDATE: Credit Suisse Assumes Coverage on Molina Healthcare

Share:

In a report published Thursday, Credit Suisse analyst Chris Carter assumed coverage on Molina Healthcare (NYSE: MOH) with a Neutral rating, raising its price target to $42.00 from $37.00

According to the report, MOH is a multistate MCO focused on government end markets. The analysts fully expect MOH to capture its fair share of a significant industry-wide market opportunity of an estimated ~$500B+ across unmanaged Medicaid, duals and exchanges.

“We believe MOH will be a net beneficiary of a secular trend toward privatization of gov't-managed health care,” the report noted. “As such, we model meaningful revenue growth in 2014-15 of +47% and +23% y/y, respectively. We also view MOH's agreement with California offering downside margin protection on state gov't business as a positive and believe take-out potential provides some level of valuation support.”

Some risks from the report included high revenue growth and 2015 revenue projections may prove too high, particularly around expectations for exchanges.

MOH closed Wednesday at $37.40 with shares trading down at 1.55 percent.

Latest Ratings for MOH

DateFirmActionFromTo
Feb 2022Morgan StanleyMaintainsOverweight
Feb 2022BMO CapitalMaintainsOutperform
Feb 2022MizuhoMaintainsBuy

View More Analyst Ratings for MOH

View the Latest Analyst Ratings

 

Related Articles (MOH)

View Comments and Join the Discussion!

Posted-In: Chris Carter Credit SuisseAnalyst Color Price Target Initiation Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com